Trial Profile
An open label pharmacokinetic study of intradermal and plasma concentration of treprostinil after iontophoresis in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Systemic scleroderma
- Focus Pharmacokinetics
- 28 Dec 2015 New trial record